Could vinegar and fasting fix prediabetes cholesterol?

NCT ID NCT07710898

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 ยท Last updated Jul 17, 2026

Summary

This study tests whether taking date cider vinegar daily, alone or combined with 5:2 intermittent fasting, can improve cholesterol and other metabolic measures in adults with prediabetes and mild to moderate high cholesterol or blood pressure. Participants are randomly assigned to standard dietary advice, vinegar alone, or vinegar plus two non-consecutive fasting days per week for three months. The goal is to see if these simple dietary changes can lower heart disease risk in people with early blood sugar problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
date cider vinegar and 5:2 intermittent fasting
What this could lead to
If it works, this could offer a simple, natural way to improve cholesterol and blood sugar in people with prediabetes, potentially reducing heart disease risk.
What could go wrong
This is a small, early study without a placebo control, so results may not be reliable or generalizable. The vinegar and fasting regimen may be hard to stick with long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

Jan 2026

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The inclusion criterion was target adults with both gender aged 35-65 years. * Adults with a diagnosis of mild to moderate hypertension * Mild hypertension (140-159/90-99 mm Hg) * Moderate hypertension (160-179/100-109 mm Hg) * Adults having mild to moderate alterations in lipid profile * Triglycerides: 150 to 499 mg/dL * LDL-C levels: Mild Alteration (130 to 159 mg/dL) and Moderate Alteration (160 to 189 mg/dL) * Adults with pre-diabetes (hbA1c= 5.6-6.4%) were used. * Patients were solicited from hospital. Exclusion Criteria: * Any Lactating and pregnant women were not included. * Any person allergic to citric acid. * Adults suffering from critical health conditions, including cancer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete mellitus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Lahore

    Lahore, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.